{'fraction_non_alphanumeric': 0.0265210608424337, 'fraction_numerical': 0.0202808112324493, 'mean_word_length': 5.173076923076923, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Analysis of the treatment patterns and safety of early breast cancer patients during the COVID-19 pandemic

The coronavirus disease 2019 (COVID-19) caused an unprecedented alteration on the diagnosis and treatment of patients with breast cancer. Studies have shown that COVID-19 is more infectious for people with lower immunity (1,2). Due to the influence of disease and treatment, the immunity of cancer patients is typically at a low level, especially for patients undergoing chemotherapy. For oncologists, it is not clear which treatment regimens are suitable and safe for breast cancer patients during the epidemic (3). Original Article